Table 1B.
Pathway name | Entities p-value | Mapped entities |
---|---|---|
HDL clearance | 0.004 | Apoa1 |
Scavenging by Class B Receptors | 0.005 | Apoa1 |
Utilization of Ketone Bodies | 0.005 | Oxct1 |
RHO GTPases Activate Rhotekin and Rhophilins | 0.008 | Tax1bp3 |
HDL assembly | 0.009 | Apoa1 |
Post-translational protein phosphorylation | 0.010 | Apoa1;Serpind1 |
Regulation of IGF transport and uptake by IGFBPs | 0.011 | Apoa1;Serpind1 |
HDL remodeling | 0.012 | Apoa1 |
Chylomicron remodeling | 0.013 | Apoa1 |
Chylomicron assembly | 0.013 | Apoa1 |
Scavenging by Class A Receptors | 0.013 | Apoa1 |
Ketone body metabolism | 0.013 | Oxct1 |
Dermatan sulfate biosynthesis | 0.014 | Bgn |
Heme signaling | 0.014 | Apoa1 |
CS/DS degradation | 0.018 | Bgn |
Metabolism of Angiotensinogen to Angiotensins | 0.021 | Agt |
ABC transporters in lipid homeostasis | 0.022 | Apoa1 |
Plasma lipoprotein assembly | 0.024 | Apoa1 |
Chondroitin sulfate biosynthesis | 0.026 | Bgn |
Common Pathway of Fibrin Clot Formation | 0.027 | Serpind1 |
Intrinsic Pathway of Fibrin Clot Formation | 0.030 | Serpind1 |
A tetrasaccharide linker sequence is required for GAG synthesis | 0.034 | Bgn |
Plasma lipoprotein remodeling | 0.035 | Apoa1 |
Plasma lipoprotein clearance | 0.039 | Apoa1 |
The pathways listed here are altered by the significantly upregulated proteins with the intervention “Aquamin” presented in Table 1A. Reactome (v78) was used to generate the pathway analysis report for species Mus musculus. The significance (p-value) is calculated by the overrepresentation analysis (hypergeometric distribution). IGF, Insulin-like Growth Factor; IGFBPs, Insulin-like growth factor binding proteins.